Transferrin Saturation Coefficient and Ferritinemia in Diagnosis of Iron Deficiency (CarenceMartial)

October 23, 2019 updated by: Lille Catholic University

Accordance Between Transferrin Saturation Coefficient and Ferritinemia in Diagnosis of Iron Deficiency, in Patients Hospitalised in Internal Medicine Service and 65 Years Old and More

Transferrin saturation coefficient and ferritinemia in diagnosis of iron deficiency

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

136

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
    • Nord
      • Lomme, Nord, France, 59462
        • Saint-Philibert hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

63 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Elderly people hospitalized in the internal medicine and geriatry service

Description

Inclusion Criteria:

  • ≥ 65 years old
  • Patient hospitalized in the internal medicine and geriatry service
  • Patient affiliated with a social security scheme
  • Patient signed an Informed consent

Exclusion Criteria:

  • Risk benefit balance not in favor of iron deficiency check-up
  • Patient in palliative care

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Hospitalized patients aged 65 and over
- Patients aged 65 and over hospitalized in the department of Internal Medicine and Geriatry
Diagnostic test: biologic analysis (ferritinemia, transferrin saturation coefficient)
Each patient will follow a blood test in order to compare between ferritinemia and transferrin saturation coefficient in iron deficiency diagnosis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Agreement between Transferrin Saturation Coefficient (TSC) and ferritinemia dosage
Time Frame: Day one
The overall agreement, assessed by kappa Cohen
Day one

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of iron deficiency with and without anaemia
Time Frame: Day one
Number of patients with iron deficiency with or without anaemia
Day one
Prevalence of etiologies of iron deficiency
Time Frame: Day one
Number of patients for each etiology
Day one
Prevalence of iron deficiency in patients with anticoagulant and platelet aggregation inhibitor
Time Frame: Day one
Day one

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Lille Catholic University

Investigators

  • Principal Investigator: Hélène Bulckaen, MD, Groupement des Hôpitaux de l'institut Catholique de Lille

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 6, 2019

Primary Completion (Actual)

September 30, 2019

Study Completion (Actual)

September 30, 2019

Study Registration Dates

First Submitted

October 23, 2019

First Submitted That Met QC Criteria

October 23, 2019

First Posted (Actual)

October 25, 2019

Study Record Updates

Last Update Posted (Actual)

October 25, 2019

Last Update Submitted That Met QC Criteria

October 23, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RC-P0079

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Iron-deficiency

Clinical Trials on biologic analysis (ferritinemia, transferrin saturation coefficient)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Nigeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe